Journal Club
Sorafenib extends PFS for refractory desmoid tumors
The oral tyrosine kinase inhibitor was associated with durable responses and a high progression-free survival rate in patients with refractory or...
Rare Sarcomas
Conference Coverage
Reports from the annual meeting of The Connective Tissue Oncology Society held in Rome, November 14-17, 2018 Sarcoma of the Year: Intimal Sarcoma
Sarcoma of the Year: Intimal Sarcoma
Sponsored Supplement
Understanding Cholangiocarcinoma: How Biomarker Testing Can Lead to a Targeted Treatment for Patients
From the Journals
TKIs and immunotherapy hold promise for alveolar soft part sarcoma
Tyrosine kinase inhibitors and immune checkpoint inhibitors show encouraging results in the treatment of alveolar soft part sarcoma
Physician Resources
Childhood soft tissue sarcoma: Professional resources from the National Cancer Institute
Physician Resources
Kaposi sarcoma: Professional resources from the National Cancer Institute
Case Reports
Anti-PD-1 therapy with nivolumab in the treatment of metastatic malignant PEComa
Perivascular epithelioid cell neoplasms (PEComas) are an uncommon class of tumors consisting on histology of perivascular epithelioid cells...
Case Reports
Pulmonary sarcomatoid carcinoma presenting as a necrotizing cavitary lung lesion: diagnostic dilemma
Pulmonary sarcomatoid carcinoma (PSC) is a rare histological subtype that has an aggressive course with average survival of 11-13 months.1 In...
Case Reports
Bilateral chylothorax in an AIDS patient with newly diagnosed Kaposi sarcoma
Kaposi sarcoma is an angioproliferative tumor that is associated with human herpes virus-B (HIV-B). Mucocutaneous disease is the most common site...